{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:42:53Z","timestamp":1794012173919,"version":"4.8.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Aim:<\/jats:title>\n            <jats:p>The authors aimed to perform a meta-analysis to evaluate the association between herpes simplex virus (HSV) infection and the risk of developing dementia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The authors searched the following databases: PubMed, Scopus, Cochrane Library, and Web of Science. The authors included any randomized control trials and controlled observational studies that investigated the prevalence of dementia in HSV-infected patients and HSV-free control group. Also, if the studies measured the levels of HSV antibodies and incidence of these antibodies in patients with dementia compared with a healthy control group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>After a comprehensive literature search, 19 studies were included in the meta-analysis with 342\u00a0535 patients included in the analysis. The pooled analysis showed a statistically significant association between Alzheimer\u2019s disease (AD), mild cognitive impairment (MCI), and increased levels of IgG titer group [mean difference (MD) = 0.99, 95% confidence interval (CI) = 0.36\u20131.63, <jats:italic toggle=\"yes\">P<\/jats:italic>-value = 0.002], (MD = 0.80, 95% CI = 0.26\u20131.35, <jats:italic toggle=\"yes\">P<\/jats:italic>-value = 0.004), respectively. Additionally, the generic inverse variance showed a statistically significant association between the HSV group and increased incidence of dementia compared with the no HSV control group [risk ratio (RR) = 2.23, 95% CI = 1.18\u20132.29, <jats:italic toggle=\"yes\">P<\/jats:italic>-value &lt;0.00001]. Moreover, this analysis showed no statistically significant difference between the AD group and the control group in anti-HSV IgM titer <jats:italic toggle=\"yes\">n<\/jats:italic> (%) outcome (RR = 1.35, 95% CI = 0.91\u20132.01, <jats:italic toggle=\"yes\">P<\/jats:italic>-value = 0.14), respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study revealed that AD and MCI patients have increased levels of IgG antibodies titer against HSV infection. The study showed a significant association between HSV infection and increased incidence of dementia. Thus, regular follow-up of HSV patients\u2019 IgG titer levels could be useful in the prevention of dementia in these patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000000951","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T17:01:47Z","timestamp":1696438907000},"page":"5060-5074","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Herpes simplex virus infection and the risk of dementia: a systematic review and meta-analysis"],"prefix":"10.1097","volume":"85","author":[{"given":"Rowan H.","family":"Elhalag","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karam R.","family":"Motawea","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesreen E.","family":"Talat","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah S.","family":"Rouzan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsayed M.","family":"Hammad","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarraa M.","family":"Reyad","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai S.","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaffer","family":"Shah","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10]]},"reference":[{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2017.96","article-title":"A clinicopathological approach to the diagnosis of dementia","volume":"13","author":"Elahi","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"R4-20250806","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev.publhealth.23.100901.140525","article-title":"The public health impact of Alzheimer\u2019s disease, 2000\u20132050: potential implication of treatment advances","volume":"23","author":"Sloane","year":"2002","journal-title":"Annu Rev Public Health"},{"key":"R5-20250806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-017-0297-z","article-title":"therapy. Alzheimer\u2019s disease prevention: from risk factors to early intervention","volume":"9","author":"Crous-Bou","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jalz.2017.02.001","article-title":"2017 Alzheimer\u2019s disease facts and figures","volume":"13","year":"2017","journal-title":"Alzheimers Dement"},{"key":"R7-20250806","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3233\/JAD-141134","article-title":"Epidemiological and economic burden of Alzheimer\u2019s disease: a systematic literature review of data across Europe and the United States of America","volume":"43","author":"Takizawa","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch Neurol"},{"key":"R9-20250806","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment\u2013beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J Intern Med"},{"key":"R11-20250806","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1017\/S1092852918001347","article-title":"State of the science on mild cognitive impairment (MCI)","volume":"24","author":"Anderson","year":"2019","journal-title":"CNS Spectr"},{"key":"R12-20250806","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/archneurol.2009.106","article-title":"Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts","volume":"66","author":"Farias","year":"2009","journal-title":"Arch Neurol"},{"key":"R13-20250806","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/msj.20157","article-title":"Neuropathology of Alzheimer\u2019s disease","volume":"77","author":"DP","year":"2010","journal-title":"Mt Sinai J Med"},{"key":"R14-20250806","doi-asserted-by":"crossref","first-page":"748212","DOI":"10.1155\/2015\/748212","article-title":"Working memory and executive function decline across normal aging, mild cognitive impairment, and Alzheimer\u2019s disease","volume":"2015","author":"Kirova","year":"2015","journal-title":"Biomed Res Int"},{"key":"R15-20250806","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-micro-092412-155654","article-title":"An inquiry into the molecular basis of HSV latency and reactivation","volume":"67","author":"Roizman","year":"2013","journal-title":"Annu Rev Microbiol"},{"key":"R16-20250806","doi-asserted-by":"crossref","first-page":"e0140765","DOI":"10.1371\/journal.pone.0140765","article-title":"Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012","volume":"10","author":"Looker","year":"2015","journal-title":"PLoS One"},{"key":"R17-20250806","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(19)30470-0","article-title":"Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological data","volume":"20","author":"Looker","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"R18-20250806","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.jalz.2018.06.3040","article-title":"The antimicrobial protection hypothesis of Alzheimer\u2019s disease","volume":"14","author":"Moir","year":"2018","journal-title":"Alzheimers Dement"},{"key":"R19-20250806","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/13550280590922793","article-title":"Olfactory transmission of neurotropic viruses","volume":"11","author":"Mori","year":"2005","journal-title":"J NeuroVirol"},{"key":"R21-20250806","doi-asserted-by":"crossref","first-page":"16m11312","DOI":"10.4088\/JCP.16m11312","article-title":"Herpes zoster and dementia: a nationwide population-based cohort study","volume":"79","author":"Chen","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"R22-20250806","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fnagi.2018.00324","article-title":"Corroboration of a major role for herpes simplex virus type 1 in Alzheimer\u2019s disease","volume":"10","author":"Itzhaki","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"R23-20250806","doi-asserted-by":"crossref","first-page":"e0188490","DOI":"10.1371\/journal.pone.0188490","article-title":"Increased risk of dementia following herpes zoster ophthalmicus","volume":"12","author":"Tsai","year":"2017","journal-title":"PLoS One"},{"key":"R24-20250806","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13311-018-0611-x","article-title":"Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections\u2014a nationwide, population-based cohort study in Taiwan","volume":"15","author":"Tzeng","year":"2018","journal-title":"Neurotherapeutics"},{"key":"R25-20250806","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1007\/s13311-021-01084-9","article-title":"Symptomatic herpes simplex virus infection and risk of dementia in US veterans: a cohort study","volume":"18","author":"Young-Xu","year":"2021","journal-title":"Neurotherapeutics"},{"key":"R27-20250806","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R28-20250806","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"R29-20250806","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3233\/JAD-170966","article-title":"HSV-1-specific IgG subclasses distribution and serum neutralizing activity in Alzheimer\u2019s disease and in mild cognitive impairment","volume":"63","author":"Agostini","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"R30-20250806","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/ene.12477","article-title":"A study on the association between infectious burden and Alzheimer\u2019s disease","volume":"22","author":"Bu","year":"2015","journal-title":"Eur J Neurol"},{"key":"R31-20250806","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3233\/JAD-170520","article-title":"Modulation of immune responses to herpes simplex virus type 1 by IFNL3 and IRF7 polymorphisms: a study in Alzheimer\u2019s disease","volume":"60","author":"Costa","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"R32-20250806","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ana.10662","article-title":"Herpes viruses in brains in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"54","author":"Hemling","year":"2003","journal-title":"Ann Neurol"},{"key":"R33-20250806","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(96)10149-5","article-title":"Herpes simplex virus type 1 in brain and risk of Alzheimer\u2019s disease","volume":"349","author":"Itzhaki","year":"1997","journal-title":"Lancet"},{"key":"R34-20250806","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/path.1127","article-title":"Herpesviruses in brain and Alzheimer\u2019s disease","volume":"197","author":"Lin","year":"2002","journal-title":"J Pathol"},{"key":"R35-20250806","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jalz.2014.07.157","article-title":"Herpes simplex infection and the risk of Alzheimer\u2019s disease: a nested case-control study","volume":"11","author":"L\u00f6vheim","year":"2015","journal-title":"Alzheimers Dement"},{"key":"R36-20250806","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fnagi.2014.00285","article-title":"Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer\u2019s disease and amnestic mild cognitive impairment","volume":"6","author":"Mancuso","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"R37-20250806","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3233\/JAD-130977","article-title":"Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer\u2019s disease","volume":"38","author":"Mancuso","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"R38-20250806","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3233\/JAD-190265","article-title":"Immunoglobulin genes and immunity to HSV1 in Alzheimer\u2019s disease","volume":"70","author":"Pandey","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"R40-20250806","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/jmv.20271","article-title":"Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer\u2019s disease patients","volume":"75","author":"Wozniak","year":"2005","journal-title":"J Med Virol"},{"key":"R41-20250806","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bbi.2016.07.153","article-title":"High avidity HSV-1 antibodies correlate with absence of amnestic mild cognitive impairment conversion to Alzheimer\u2019s disease","volume":"58","author":"Agostini","year":"2016","journal-title":"Brain Behav Immun"},{"key":"R42-20250806","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/vaccines8020255","article-title":"HSV-1-specific IgG(3) titers correlate with brain cortical thinning in individuals with mild cognitive impairment and Alzheimer\u2019s disease","volume":"8","author":"Mancuso","year":"2020","journal-title":"Vaccines"},{"key":"R43-20250806","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/ageing\/16.5.311","article-title":"A sero-epidemiological study of conventional infectious agents in Alzheimer\u2019s disease","volume":"16","author":"Renvoize","year":"1987","journal-title":"Age Ageing"},{"key":"R44-20250806","doi-asserted-by":"crossref","first-page":"e3637","DOI":"10.1371\/journal.pone.0003637","article-title":"Seropositivity to herpes simplex virus antibodies and risk of Alzheimer\u2019s disease: a population-based cohort study","volume":"3","author":"Letenneur","year":"2008","journal-title":"PLoS One"},{"key":"R45-20250806","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1017\/S0317167100044115","article-title":"Limbic predilection in Alzheimer dementia: is reactivated herpesvirus involved?","volume":"9","author":"Ball","year":"1982","journal-title":"Can J Neurol Sci"},{"key":"R46-20250806","doi-asserted-by":"crossref","first-page":"e0134178","DOI":"10.1371\/journal.pone.0134178","article-title":"Seroprevalence of herpes simplex virus type 1 and 2 in Taiwan and risk factor analysis, 2007","volume":"10","author":"Shen","year":"2015","journal-title":"PLoS One"},{"key":"R47-20250806","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/ene.14795","article-title":"Antiherpetic medication and incident dementia: observational cohort studies in four countries","volume":"28","author":"Schnier","year":"2021","journal-title":"Eur J Neurol"},{"key":"R48-20250806","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"R49-20250806","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.neuroimage.2017.03.057","article-title":"A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer\u2019s disease and its prodromal stages","volume":"155","author":"Rathore","year":"2017","journal-title":"Neuroimage"},{"key":"R50-20250806","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ana.410360605","article-title":"Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction","volume":"36","author":"Baringer","year":"1994","journal-title":"Ann Neurol"},{"key":"R51-20250806","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/jnnp.48.4.297","article-title":"The limbic system and the localisation of herpes simplex encephalitis","volume":"48","author":"Damasio","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R52-20250806","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-510X(82)90183-6","article-title":"Herpes simplex encephalitis. An immunohistological study of the distribution of viral antigen within the brain","volume":"54","author":"Esiri","year":"1982","journal-title":"J Neurol Sci"},{"issue":"Pt 4","key":"R53-20250806","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1099\/0022-1317-69-4-847","article-title":"Murine IgG subclass responses to herpes simplex virus type 1 and polypeptides","volume":"69","author":"McKendall","year":"1988","journal-title":"J Gen Virol"},{"key":"R54-20250806","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bbrc.2012.12.054","article-title":"Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer\u2019s disease","volume":"430","author":"Kobayashi","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"R55-20250806","first-page":"46","article-title":"[Detection of low avidity IgG as a promising approach to diagnosis of primary herpetic infection]","volume":"49","author":"Ebralidze","year":"2004","journal-title":"Voprosy Virusologii"},{"key":"R56-20250806","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-2009-0963","article-title":"Alzheimer\u2019s disease-specific tau phosphorylation is induced by herpes simplex virus type 1","volume":"16","author":"Wozniak","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"R57-20250806","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neulet.2007.09.077","article-title":"Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation","volume":"429","author":"Wozniak","year":"2007","journal-title":"Neurosci Lett"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000000951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:18:38Z","timestamp":1754486318000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000000951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":52,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000000951","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,26]]},"assertion":[{"value":"2023-03-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}